VERCYTE Side Effects

6867808-4 | Acute Myeloid Leukaemia, Breast Cancer, Lung Infection
on Jul 21, 2010 Female patient from FRANCE , 75 years of age, was diagnosed with essential thrombocythaemia, breast cancer (What is breast cancer?) and was treated with Vercyte (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, breast cancer (What is breast cancer?), lung infection. Vercyte dosage: . During the same period patient was treated with HYDREA (View Hydrea Review and Hydrea Label ), XAGRID (View Xagrid Review and Xagrid Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), TAXOL (View Taxol Review and Taxol Label ), HERCEPTIN (View Herceptin Review and Herceptin Label ).

6723758-5 | Dermatitis Contact
Patient was taking Vercyte (View Usage). Patient had the following side effects: dermatitis contact on May 06, 2010 from FRANCE Additional patient health information: Female patient , weighting 134.5 lb, was diagnosed with leukaemia and. Vercyte dosage: . During the same period patient was treated with SENOPHILE (View Senophile Review and Senophile Label ), CREAM WITH LAVENDER (NOS) (View Cream With Lavender (nos) Review and Cream With Lavender (nos) Label ), CREAM WITH CALENDULA (NOS) (View Cream With Calendula (nos) Review and Cream With Calendula (nos) Label ). Patient was hospitalized.

6690959-4 | Hepatic Lesion, Pancytopenia, Purpura, Renal Failure
Adverse event was reported on Apr 13, 2010 by a Male patient taking Vercyte (View Usage) (Dosage: ) was diagnosed with thrombocytopenia and. Location: FRANCE , 67 years of age, weighting 260.1 lb, After Vercyte was administered, patient had the following side effects: hepatic lesion, pancytopenia, purpura, renal failure. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6673652-3 | Pancytopenia
on Apr 01, 2010 Female patient from FRANCE , 77 years of age, was treated with Vercyte (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia. Vercyte dosage: . Patient was hospitalized.


6253019-2 | Acute Myeloid Leukaemia, Breast Cancer, Lung Infection
on Jun 22, 2009 Female patient from FRANCE , 75 years of age, was diagnosed with essential thrombocythaemia, breast cancer (What is breast cancer?) and was treated with Vercyte (View Usage). Patient had the following side effects: acute myeloid leukaemia, breast cancer (What is breast cancer?), lung infection. Vercyte dosage: . During the same period patient was treated with HYDREA (View Hydrea Review and Hydrea Label ), XAGRID (View Xagrid Review and Xagrid Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), TAXOL (View Taxol Review and Taxol Label ), HERCEPTIN (View Herceptin Review and Herceptin Label ).

6216423-4 | Acute Myeloid Leukaemia, Breast Cancer, Lung Infection
Patient was taking Vercyte (View Usage). After Vercyte was administered, patient had the following side effects: acute myeloid leukaemia, breast cancer (What is breast cancer?), lung infection on May 27, 2009 from FRANCE Additional patient health information: Female patient , 75 years of age, was diagnosed with essential thrombocythaemia, breast cancer (What is breast cancer?) and. Vercyte dosage: . During the same period patient was treated with HYDREA (View Hydrea Review and Hydrea Label ), XAGRID (View Xagrid Review and Xagrid Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), TAXOL (View Taxol Review and Taxol Label ), HERCEPTIN (View Herceptin Review and Herceptin Label ).

6211487-6 | Acute Myeloid Leukaemia, Anaemia
Adverse event was reported on May 22, 2009 by a Female patient taking Vercyte (View Usage) (Dosage: ) was diagnosed with essential thrombocythaemia and. Location: FRANCE , 81 years of age, Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, anaemia. During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), PREVISCAN (View Previscan Review and Previscan Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), TEVETEN (View Teveten Review and Teveten Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), LASIX (View Lasix Review and Lasix Label ), KALEORID (View Kaleorid Review and Kaleorid Label ), BRICANYL (View Bricanyl Review and Bricanyl Label ). Patient was hospitalized.

6078247-0 | Deep Vein Thrombosis, Pulmonary Embolism, Thrombocytopenia
on Feb 04, 2009 Female patient from FRANCE , 78 years of age, was diagnosed with thrombocytopenia, pulmonary embolism (What is pulmonary embolism?) and was treated with Vercyte (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?), thrombocytopenia. Vercyte dosage: . During the same period patient was treated with HEPARIN (At Curative Dose) (View Heparin Review and Heparin Label ), DANAPAROID SODIUM (View Danaparoid Sodium Review and Danaparoid Sodium Label ). Patient was hospitalized.

6054361-0 | Acute Myeloid Leukaemia
on Jan 19, 2009 Female patient from FRANCE , 47 years of age, was diagnosed with thrombocythaemia and was treated with Vercyte (View Usage). After Vercyte was administered, patient had the following side effects: acute myeloid leukaemia. Vercyte dosage: . During the same period patient was treated with HYDROXYCARBAMID (View Hydroxycarbamid Review and Hydroxycarbamid Label ), ANAGRELID (View Anagrelid Review and Anagrelid Label ).

6054220-3 | Acute Myeloid Leukaemia
Patient was taking Vercyte (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia on Jan 19, 2009 from FRANCE Additional patient health information: Female patient , 47 years of age, was diagnosed with thrombocythaemia and. Vercyte dosage: . During the same period patient was treated with HYDROXYCARBAMID (View Hydroxycarbamid Review and Hydroxycarbamid Label ), ANAGRELID (View Anagrelid Review and Anagrelid Label ).

5842319-3 | Polycythaemia Vera
Adverse event was reported on Aug 07, 2008 by a Female patient taking Vercyte (View Usage) (Dosage: ) was diagnosed with polycythaemia vera, osteoporosis (What is osteoporosis?), hypertension and. Location: FRANCE , 76 years of age, Patient had the following side effects: polycythaemia vera. During the same period patient was treated with TERIPARATIDE (View Teriparatide Review and Teriparatide Label ), AMLODIPINE MALEATE (View Amlodipine Maleate Review and Amlodipine Maleate Label ), GALENIC /BENAZEPRIL/HYDROCHLOROTHIAZIDE/ (View Galenic /benazepril/hydrochlorothiazide/ Review and Galenic /benazepril/hydrochlorothiazide/ Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

5821907-4 | Polycythaemia Vera
on Jul 17, 2008 Female patient from FRANCE , 76 years of age, was diagnosed with polycythaemia vera, osteoporosis (What is osteoporosis?), hypertension and was treated with Vercyte (View Usage). After Vercyte was administered, patient had the following side effects: polycythaemia vera. Vercyte dosage: . During the same period patient was treated with TERIPARATIDE (View Teriparatide Review and Teriparatide Label ), AMLODIPINE MALEATE (View Amlodipine Maleate Review and Amlodipine Maleate Label ), GALENIC /BENAZEPRIL/HYDROCHLOROTHIAZIDE/ (View Galenic /benazepril/hydrochlorothiazide/ Review and Galenic /benazepril/hydrochlorothiazide/ Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

5479995-3 | Agranulocytosis, Anaemia, Aplasia, Bone Marrow Failure, Pancytopenia
on Oct 01, 2007 Female patient from FRANCE , weighting 138.9 lb, was diagnosed with polycythaemia vera and was treated with Vercyte (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, anaemia, aplasia, bone marrow failure, pancytopenia. Vercyte dosage: . Patient was hospitalized.

5221560-7 | Acute Leukaemia
Patient was taking Vercyte (View Usage). Patient had the following side effects: acute leukaemia on Jan 17, 2007 from FRANCE Additional patient health information: Female patient , 77 years of age, was diagnosed with myeloproliferative disorder and. Vercyte dosage: .

5200281-0 | Acute Leukaemia, Cardiac Failure, Chest Pain, Oliguria, Painful Respiration, Sepsis, Tachypnoea
Adverse event was reported on Dec 28, 2006 by a Male patient taking Vercyte (View Usage) (Dosage: ) was diagnosed with polycythaemia vera and. Location: FRANCE , 76 years of age, After Vercyte was administered, patient had the following side effects: acute leukaemia, cardiac failure, chest pain (What is chest pain?), oliguria, painful respiration, sepsis (What is sepsis?), tachypnoea. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PIPERACILLIN (View Piperacillin Review and Piperacillin Label ), TAZOBACTAM (View Tazobactam Review and Tazobactam Label ). Patient was hospitalized.

5153464-2 | Acute Leukaemia, Cardiac Failure, Chest Pain, Sepsis, Unevaluable Event
on Oct 24, 2006 Male patient from FRANCE , 76 years of age, was diagnosed with polycythaemia vera and was treated with Vercyte (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia, cardiac failure, chest pain (What is chest pain?), sepsis (What is sepsis?), unevaluable event. Vercyte dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PIPERACILLIN (View Piperacillin Review and Piperacillin Label ), TAZOBACTAM (View Tazobactam Review and Tazobactam Label ). Patient was hospitalized.

5143731-0 | Acute Leukaemia
on Oct 24, 2006 Male patient from FRANCE , 76 years of age, was diagnosed with polycythaemia vera and was treated with Vercyte (View Usage). Patient had the following side effects: acute leukaemia. Vercyte dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5126259-3 | Anaemia
Patient was taking Vercyte (View Usage). After Vercyte was administered, patient had the following side effects: anaemia on Oct 02, 2006 from FRANCE Additional patient health information: Male patient , 84 years of age, was diagnosed with thrombocytopenia and. Vercyte dosage: . During the same period patient was treated with LEVODOPA BENSERAZIDE (View Levodopa Benserazide Review and Levodopa Benserazide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), GINKGO BILOBA (View Ginkgo Biloba Review and Ginkgo Biloba Label ). Patient was hospitalized.

5078822-6 | Varicose Ulceration
Adverse event was reported on Aug 03, 2006 by a Female patient taking Vercyte (View Usage) (Dosage: ) was diagnosed with essential thrombocythaemia, thrombocytopenia and. Location: FRANCE , 86 years of age, Patient experienced the following unwanted or unexpected effects: varicose ulceration. During the same period patient was treated with HYDROXYCARBAMIDE (View Hydroxycarbamide Review and Hydroxycarbamide Label ). Patient was hospitalized.

5064994-6 | Myelofibrosis, Pancytopenia
on Jun 28, 2006 Female patient from FRANCE , 77 years of age, was treated with Vercyte (View Usage). Patient had the following side effects: myelofibrosis, pancytopenia. Vercyte dosage: . Patient was hospitalized.

5050937-8 | Abdominal Strangulated Hernia, Cerebrovascular Accident, Dyspepsia, Gastric Ulcer, Prepyloric Stenosis, Scar
on Jul 03, 2006 Male patient from FRANCE , 76 years of age, weighting 211.6 lb, was diagnosed with polycythaemia and was treated with Vercyte (View Usage). After Vercyte was administered, patient had the following side effects: abdominal strangulated hernia, cerebrovascular accident, dyspepsia, gastric ulcer, prepyloric stenosis, scar (What is scar?). Vercyte dosage: . During the same period patient was treated with DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), TAMSULOSINE (View Tamsulosine Review and Tamsulosine Label ), ALPHACALCIDOL (View Alphacalcidol Review and Alphacalcidol Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), GLYCERYL TRINITRATE (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ). Patient was hospitalized.

5043657-7 | Myelofibrosis, Pancytopenia
Patient was taking Vercyte (View Usage). Patient experienced the following unwanted or unexpected effects: myelofibrosis, pancytopenia on Jun 28, 2006 from FRANCE Additional patient health information: Female patient , 77 years of age, . Vercyte dosage: . Patient was hospitalized.

5011423-4 | Acute Megakaryocytic Leukaemia
Adverse event was reported on May 17, 2006 by a Female patient taking Vercyte (View Usage) (Dosage: ) was diagnosed with polycythaemia vera and. Location: FRANCE , 80 years of age, weighting 121.3 lb, Patient had the following side effects: acute megakaryocytic leukaemia. During the same period patient was treated with MELILOT/RUTOSIDE (View Melilot/rutoside Review and Melilot/rutoside Label ), PYRIDOSTIGMINE BROMIDE (View Pyridostigmine Bromide Review and Pyridostigmine Bromide Label ), GLYCERYL TRINITRATE (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ).

4895818-5 | Myelodysplastic Syndrome
on Jan 20, 2006 Female patient from FRANCE , 79 years of age, was diagnosed with polycythaemia vera and was treated with Vercyte (View Usage). After Vercyte was administered, patient had the following side effects: myelodysplastic syndrome. Vercyte dosage: .

4641337-0 | Hepatic Lesion, Pancytopenia, Purpura, Renal Failure
on Apr 06, 2005 Male patient from , 67 years of age, weighting 260.1 lb, was diagnosed with thrombocytopenia and was treated with Vercyte (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic lesion, pancytopenia, purpura, renal failure. Vercyte dosage: 25 Mg, 1 In 1 D, Per Oral. During the same period patient was treated with ALLOPURINOL (300 Mg , 1 In 1 D, Per Oral) (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

4635863-8 | Hepatic Lesion, Pancytopenia, Purpura, Renal Failure
Patient was taking Vercyte (View Usage). Patient had the following side effects: hepatic lesion, pancytopenia, purpura, renal failure on Apr 06, 2005 from Additional patient health information: Male patient , 67 years of age, weighting 260.1 lb, was diagnosed with thrombocytopenia and. Vercyte dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.